Internal Medicine • Research • Visualized VISUALIZED: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification 1 min read Read further: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification FacebookXPinterestLinkedIn
Article NL C.74 (2026) • Internal Medicine Evaluating Antiseizure Medication Selection and... 3 min read
Article NL C.74 (2026) • Internal Medicine Protein Delivery of ABE8e-V106W Base Editors Supports... 3 min read
Article NL C.74 (2026) • Internal Medicine Mechanistic Insights Into Statin Chemoprevention... 3 min read
Article NL C.72(2026) • Internal Medicine Targeting EFHD1 Calcium-Dependent Organellar Contact... 3 min read
Article NL C.72(2026) • Internal Medicine Neurological and Systemic Complications of Varicella... 3 min read